Scientific in Medical Technology

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... strength of the data, which we will present in a scientific forum later this year. We are also looking ... business and results of operations. The scientific information discussed in this news release ... for the use(s) being investigated. Further, the scientific information discussed in this news release ...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

... organic chemical products and kits are used in scientific and genomic research, biotechnology, ... studies, publish over 1,300 peer-reviewed scientific papers, and provide care in virtually every ... 643 is a French public academic laboratory. Its scientific activity is centered in the analysis of immune ...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

... applications was provided by the U.S. Probiotics scientific Board Selection Committee, which is comprised of ... Sanders, PhD, Executive Director, International scientific Association for Probiotics and Prebiotics ... began with the establishment of the Probiotics scientific Board in the United States. The Young ...

Spherix Announces Positive Phase 2 Study Results

... Spherix Incorporated was launched in 1967 as a scientific research company, under the name Biospherics Research. The company now leverages its scientific and technical expertise and experience through ... Its Spherix Consulting subsidiary provides scientific and strategic support for suppliers, ...

New Therapy Found to Prevent Heart Failure

... to 2008, Moss received honoraria from Boston scientific for talks at scientific programs. He holds no stock in any device ... 1, 2008, has received no honoraria from Boston scientific for any professional activity. ...

MADIT-CRT Trial Meets Primary Endpoint

... Landmark trial shows Boston scientific CRT-Ds slow the progression of heart failure in ... Mass., June 23 /PRNewswire-FirstCall/ -- Boston scientific Corporation (NYSE: BSX ) and the University of ... endpoint. Preliminary results show Boston scientific cardiac resynchronization therapy defibrillators ...

New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients

... at the American Society of Echocardiography's scientific Sessions WASHINGTON, June 8 /PRNewswire/ ... their most-recent findings at its 20th Annual scientific Sessions, June 6-10, at the Gaylord National ... surgery, according to research unveiled at ASE's scientific Sessions. By using cardiovascular ultrasound and ...

Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk

... at the American Diabetes Association's 69th scientific Sessions Expand on Previously Announced Positive ... at the American Diabetes Association's 69th scientific Sessions. Lorcaserin patients achieved highly ... "We are pleased to present the BLOOM data in a scientific forum. In this trial, lorcaserin helped patients ...

AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA

... at the American Diabetes Association's 69th scientific Sessions shows investigational product comparable ... today at the American Diabetes Association's 69th scientific Sessions. Results from the prospective, ... Richardson, Corporate Vice President and Chief scientific Officer, MannKind Corporation. "Our encouraging ...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

... H. Koch Institute at MIT . Sharp chairs the scientific Advisory Committee (SAC) assembled by SU2C's scientific partner, the American Association for Cancer ... Americans who will be diagnosed this year, scientific breakthroughs can literally be a matter of life ...

Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial

... Mass., May 26 /PRNewswire-FirstCall/ -- Boston scientific Corporation (NYSE: BSX ) today welcomed ... aneurysms," said Mark Paul, President, Boston scientific Neurovascular. "The data from ISAT over the last ... is placed across the aneurysm. Boston scientific is a worldwide developer, manufacturer and ...

Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease

... Mass., May 20 /PRNewswire-FirstCall/ -- Boston scientific Corporation (NYSE: BSX ) today announced the ... said Donald S. Baim, M.D., Chief Medical and scientific Officer of Boston Scientific. "The EPIC Stent is ... not available for sale in the U.S. Boston scientific is a worldwide developer, manufacturer and ...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

... Spain, May 20 /PRNewswire-FirstCall/ -- Boston scientific Corporation (NYSE: BSX ) today announced ... Utrecht, The Netherlands, at the annual EuroPCR scientific Program in Barcelona. "This analysis ... left main or three-vessel disease. Boston scientific is a worldwide developer, manufacturer and ...

Mutant Genes in High-Risk Childhood Leukemias Identified

... the remaining high-risk patients," said St. Jude scientific Director, James Downing, M.D., a co-senior author ... St. Jude freely shares its discoveries with scientific and medical communities around the world. No ... committed to conquering childhood cancer through scientific discovery and compassionate care. For more ...

Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent

... Mass., May 19 /PRNewswire-FirstCall/ -- Boston scientific Corporation (NYSE: BSX ) today announced the ... stent innovation," said David McFaul, Boston scientific Senior Vice President, International. "This ... at the Transcatheter Cardiovascular Therapeutics scientific symposium in 2008; global pivotal trials are ...

Spherix Reports First Quarter 2009 Earnings

... Spherix Incorporated was launched in 1967 as a scientific research company, under the name Biospherics Research. The company now leverages its scientific and technical expertise and experience through ... Its Spherix Consulting subsidiary provides scientific and strategic support for suppliers, ...

TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry

... devices announced today at the 30th Annual scientific Sessions of the Heart Rhythm Society the initial, ... During the Heart Rhythm Society 2009 Annual scientific Sessions*, TYRX held an AIGIS Retrospective ... was not part of the Heart Rhythm 2009 Official scientific Sessions as planned by the ...

Spherix Elects New Independent Director, and Elects Chairman of the Board

... Spherix Incorporated was launched in 1967 as a scientific research company, under the name Biospherics Research. The company now leverages its scientific and technical expertise and experience through ... Its Spherix Consulting subsidiary provides scientific and strategic support for suppliers, ...

New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy

... Mass., May 14 /PRNewswire-FirstCall/ -- Boston scientific Corporation (NYSE: BSX ) today announced that ... late-breaking session at the Heart Rhythm Society scientific Sessions in Boston. The analysis shows a ... MADIT II," said Fred Colen, President, Boston scientific Cardiac Rhythm Management. "More than 80 percent ...

Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials

... Mass., May 14 /PRNewswire-FirstCall/ -- Boston scientific Corporation (NYSE: BSX ) today announced data ... were presented at the Heart Rhythm Society scientific Sessions in Boston by Leslie Saxon, M.D., ... of the ALTITUDE physician panel. Boston scientific has enrolled more than 130,000 patients on the ...

New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings

... M.S., vice president - technical services and scientific affairs for Nutrition 21, stated, "These results ... studies and we remain dedicated to continuing scientific research and product development initiatives ... Biology is a multi-society, interdisciplinary, scientific meeting featuring plenary and award lectures, ...

Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent

... Mass., May 11 /PRNewswire-FirstCall/ -- Boston scientific Corporation (NYSE: BSX ) today welcomed the ... said Donald S. Baim, M.D., Chief Medical and scientific Officer of Boston Scientific. "The findings ... To date, approximately 11 million Boston scientific stents have been implanted globally, making them ...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

... unique strength in its ability to translate scientific discoveries into practical application," said Ron ... addressing some of the world's most challenging scientific problems. I am pleased to see this exciting ... the traditional route of publishing findings in a scientific journal and then seek additional research grants, ...

Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine

... Mass., May 6 /PRNewswire-FirstCall/ -- Boston scientific Corporation (NYSE: BSX ) today welcomed the ... with research grant support from Boston scientific and The Medicines Company (Nasdaq: MDCO ), is ... favorable results are maintained." "Boston scientific is proud to support this and other large clinical ...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

... in Baltimore. The ACVR is the world's largest scientific meeting devoted exclusively to research on ... PTA meetings to local high schools to explain the scientific method and discuss the safety of vaccines. ... provides current, high-quality reports of scientific progress featured in both invited presentations ...

invivodata Certified to Deliver EXACT in COPD Trials

... Dr. Nancy Kline Leidy, senior vice president of scientific affairs for UBC and Principal Investigator of the ... and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data ... devices. The company leverages a unique suite of scientific and strategic capabilities to demonstrate product ...

Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX

... Davin said, "These studies provide powerful scientific evidence that affirms the dramatic results ... Katz, Cynosure's technology is featured in seven scientific presentations at the ASLMS Annual Conference: ... Laser Medicine and Surgery is the world's largest scientific organization dedicated to promoting research, ...

Results From Study Show Promising Efficacy and Safety Results for Corthera's Relaxin in Acute Heart Failure

... Clinical Trials Session at ACC 58th Annual scientific Session; Results Published On-Line in The Lancet ... College of Cardiology's (ACC) 58th Annual scientific Session in Orlando, Fla. "The results of ... 858.717.2310 (mobile number while at ACC scientific Session) ...

Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms

... data on diabetics given the recent discussion in scientific journals regarding the difference ... for sale in the United States. Boston scientific is a worldwide developer, manufacturer and ... Media Relations Boston scientific Corporation Larry Neumann ...

Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years

... the American College of Cardiology's 58th annual scientific session in Orlando, Fla. Between two and ... a private-label version of XIENCE V to Boston scientific called the PROMUS(R) Everolimus-Eluting Coronary ... and manufactured by Abbott and supplied to Boston scientific as part of a distribution agreement between the ...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease

... Fla., March 28 /PRNewswire-FirstCall/ -- Boston scientific Corporation (NYSE: BSX ) today announced ... the American College of Cardiology (ACC) Annual scientific Sessions. "This analysis demonstrates that ... left main or three-vessel disease. Boston scientific is a worldwide developer, manufacturer and ...

AHRQ-Funded Study Finds Lower Risk of Death and Heart Attack in Patients With Drug-Coated Stent Implants Compared to Those With Bare Metal Stents

... the American College of Cardiology's 58th Annual scientific Session in Orlando, Florida. A team of ... the American College of Cardiology's 58th Annual scientific Session. This study was funded through AHRQ's ... Care Program sponsors the development of new scientific knowledge through studies on the outcomes of ...

Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack

... and other indications," stated Cardium's Chief scientific Officer, Gabor M. Rubanyi, M.D., Ph.D. ... angiogenesis. These observations provide a strong scientific rationale for the clinical development of an ... as a heart attack. Based on the large body of scientific evidence supporting IGF-1's safety, its ...

First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008

... risks in the world by supporting cutting edge scientific research. The AXA Research Fund has been endowed ... making it a major initiative in the realm of scientific philanthropy in Europe. " The current ... Four multi-year projects conducted by world-class scientific teams: Project on the impact ...

InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation

... and Nature Publishing Group (NPG) , a leading scientific and medical publisher, today announced a partnership to facilitate greater scientific collaboration and open innovation. Under the ... of scientists worldwide in solving global scientific challenges, via an online marketplace for ...

ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance

... - Company Calls for Additional scientific Data and Withdrawal of Guidance - EXTON, ... contained in the very authority cited by OGD as scientific support for its method, as well as the advice of ... of Vancocin that does not require rigorous scientific methods to demonstrate safety and efficacy ...

Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data

... Spherix Incorporated was launched in 1967 as a scientific research company, under the name Biospherics Research. The company now leverages its scientific and technical expertise and experience through ... Its Spherix Consulting subsidiary provides scientific and strategic support for suppliers, ...

Oh, My Aching Back: Give Me a Shot of Ozone

... Society of Interventional Radiology's 34th Annual scientific Meeting. In a related study, the interventional ... Hospital, Naples, Italy, SIR 34th Annual scientific Meeting March 7-12, 2009. Abstract 38: ... of Utah , Salt Lake City, Utah, SIR 34th Annual scientific Meeting March 7-12, 2009. Both abstracts can be ...

Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps

... Society of Interventional Radiology's 34th Annual scientific Meeting. Interventional radiologists often couple ... of Sassari, Sassari, Italy, SIR 34th Annual scientific Meeting March 7-12, 2009. This abstract can be ... Society of Interventional Radiology's 34th Annual scientific Meeting in San Diego. ...

Freezing Prostate Cancer Does a Man's Body Good

... Society of Interventional Radiology's 34th Annual scientific Meeting. Additionally, the use of 3-D ... Orlando , Fla. , SIR 34th Annual scientific Meeting March 7-12, 2009. Abstract 198 ... Therapy, Orlando , Fla. , SIR 34th Annual scientific Meeting March 7-12, 2009. Both abstracts can be ...